Aetion Company
Aetion provides real-world evidence (RWE) and outcomes-based analytics solutions to life science companies and payers.
Investors
Estimated Revenue:
$1M to $10M
Funding Status:
Late Stage Venture
Industry:
Data Processing
Investors Number:
18.0
Last Funding Date:
2021-05-11
Technology:
Analytics, Health Care, Software
Founded Date:
2013-01-01
Headquarters:
New York, New York, United States
Total Funding:
203600000.0
Last Funding Type:
Series C
Employee Number:
101-250